智通财经APP获悉,鉴于多数大型医疗科技公司已公开表示有意在该领域进行收购,摩根大通分析师Robbie Marcus列出了潜在的收购目标,包括:英特格拉生命科学(IART.US)、Nevro (NVRO.US)、纽瓦索器材(NUVA.US)、Silk Road Medical (SILK.US... 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000207 Size: 4 KB 网页链接
$Nevro(NVRO)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-044100 Act: 34 Size: 6 MB 网页链接
$Nevro(NVRO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-044108 Act: 34 Size: 1 MB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000204 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000200 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000201 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000202 Size: 8 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000203 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000159 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000144 Size: 6 KB 网页链接